
568: Heteroflexible Previvor
FDA Approval of H5N1 Vaccine with Adjuvants
The FDA has approved a GlaxoSmithKline H5N1 bird flu vaccine containing the adjuvant AS03 for the national stockpile. The hosts discuss the history of adjuvants like squalene and link them to cases of narcolepsy in European children following the 2009 swine flu vaccinations.







